Antipsychotic medication and social cue recognition in chronic schizophrenia

Psychiatry Research

Volumn 178, Issue 1, 2010, Pages 46-50

  Roberts, David Leland ^a   Penn, David Lewis ^b   Corrigan, Patrick ^c   Lipkovich, Ilya ^d   Kinon, Bruce ^d   Black, Ryan Andrew ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e INFLEXXION INC   (United States)

Author keywords

Signal detection; Social cognition

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE;

ADULT; ARTICLE; CHRONICITY; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OPTIMAL DRUG DOSE; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SIGNAL DETECTION; SOCIAL COGNITION; SOCIAL CUE RECOGNITION TEST; SOCIAL INTERACTION;

EID: 77956913292     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.04.006     Document Type: Article

References (41)

1. Addington, J., Saeedi, H., Addington, D., 2006. Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophrenia Research 85, 142-150.
2. Brekke, J., Kay, D.D., Lee, K.S., Green, M.F., 2005. Biosocial pathwys to functional outcome in schizophrenia. Schizophrenia Research 80, 213-225.
3. Brenner, H.D., Hodel, B., Roder, V., Corrigan, P.W., 1992. Treatment of cognitive dysfunctions and behavioral deficits in schizophrenia. Schizophrenia Bulletin 18, 21-26.
4. Brothers, L., 1990. The social brain: a project for integrating primate behavior and neurophysiology in a new domain. Concepts in Neuroscience 1, 27-61.
5. Brüne, M., Abdel-Hamid, M., Lehmkämper, C., Sonntag, C., 2007. Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best? Schizophrenia Research 92, 151-159.
6. Choi, K.H., Kwon, J.H., 2006. Social cognition enhancement training for schizophrenia: a preliminary randomized controlled trial. Community Mental Health Journal 42, 177-187.
7. Cohen, J., 1988. Statistical Power Analysis for the Behavioral Sciences. Erlbaum, Hillsdale, NJ.
8. Combs, D.R., Adams, S.D., Penn, D.L., Roberts, D.L., Tiegreen, J., Stem, P., 2007. Social cognition and interaction training for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophrenia Research 91, 112-116.
9. Combs, D.R., Tosheva, A., Penn, D.L., Basso, M.R., Wanner, J.L., Laib, K., 2008. Attentionalshaping as a means to improve emotion perception deficits in schizophrenia. Schizophrenia Research 105, 68-77.
10. Corrigan, P.W., Green, M.F., 1993. Schizophrenic patients' sensitivity to social cues: the role of abstraction. American Journal of Psychiatry 150, 589-594.
11. Corrigan, P.W., Nelson, D.R., 1998. Factors that affect social cue recognition in schizophrenia. Psychiatry Research 78, 189-196.
12. Couture, S.M., Penn, D.L., Roberts, D.L., 2006. The functional significance of social cognition in schizophrenia: a review. Schizophrenia Bulletin 32, S44-S63.
13. Dunlap, W.P., Cortina, J.M., Vaslow, J.B., Burke, M.J., 1996. Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods 1, 170-177.
14. Green, D.M., Swets, J.A., 1966. Signal Detection Theory and Psychophysics. Wiley, New York.
15. Green, M.F., Penn, D.L., Bentall, R., Carpenter, W.T., Gaebel, W., Gur, R.C., Kring, A.M., Park, S., Silverstein, S.M., Heinssen, R., 2008. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophrenia Bulletin 34, 1211-1220.
16. Harvey, P.D., Patterson, T.L., Potter, L.S., Zhong, K., Brecher, M., 2006. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning. American Journal of Psychiatry 163, 1918-1925.
17. Herbener, E.S., Hill, S.K., Marvin, R.W., Sweeney, J.A., 2005. Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia. American Journal of Psychiatry 162, 1746-1748.
18. Heyting, A., Tolboom, J.T., Essers, J.G., 1992. Statistical handling of drop-outs in longitudinal clinical trials. Statistics in Medicine 11, 2043-2061.
19. Hogarty, G.E., Flesher, S., Urlich, R., Carter, M., Greenwald, D., Pogue-Geile, M., Kechavan, M., Cooley, S., DiBarry, A.L., Garrett, A., Parepally, H., Zoretich, R., 2004. Cognitive enhancement therapy in schizophrenia. Archives of General Psychiatry 61, 866-876.
20. Horan, W.P., Kern, R.S., Shokat-Fadai, K., Sergi, M.J., Wynn, J.K., Green, M.F., 2009. Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophrenia Research 107, 47-54.
21. Jacobson, N.S., Truax, P., 1991. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59, 12-19.
22. Kee, K.S., Kern, R.S., Marshall, B.D., Green, M.F., 1998. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophrenia Research 31, 159-165.
23. Keefe, R.S.E., Sweeney, J.A., Gu, H., Hamer, R.M., Perkins, D.O., McEvoy, J.P., Lieberman, J.A., 2007. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. American Journal of Psychiatry 164, 1061-1071.
24. Kerr, S.L., Neale, J.M., 1993. Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance? Journal of Abnormal Psychology 102, 312-318.
25. Kinon, B., Noordsy, D.L., Liu-Seifert, H., Gulliver, A.H., Ascher-Svanum, H., Kollack-Walker, S., 2006. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning. Journal of Clinical Psychopharmacology 26, 453-461.
26. Kucharska-Pietura, K., David, A.S., Masiak, M., Phillips, M.L., 2005. Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. British Journal of Psychiatry 187, 523-528.
27. Littrell, K.H., Petty, R.G., Hilligoss, N.M., Kirshner, C.D., Johnson, C.G., 2004. Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine. Schizophrenia Research 66, 201-202.
28. Penn, D.L., Combs, D., 2000. Modification of affect perception deficits in schizophrenia. Schizophrenia Research 46, 217-229.
29. Penn, D.L., Addington, J., Pinkham, A., 2006. Social cognitive impairments. In: Lieberman, J.A., Stroup, T.S., Perkins, D.O. (Eds.), The American Publishing Textbook of Schizophrenia. American Psychiatric Publishing Press, Inc., Arlington, VA, pp. 261-274.
30. Penn, D.L., Roberts, D.L., Combs, D., Sterne, A., 2007. Best practices: the development of the Social Cognition and Interaction Training (SCIT) program for schizophreniaspectrum disorders. Psychiatric Services 58, 449-451.
31. Penn, D. L.,Keefe, R. S. E.,Davis, S.M.,Meyer, P. S., Perkins,D.O., Losardo, B. S., Lieberman, J. A., 2009. The effects of antipsychoticmedications on emotion perception in patients with chronic schizophrenia in the CATIE Trial. Schizophrenia Research 115, 17-23.
32. Pinkham, A.E., Penn, D.L., Perkins, D.O., Lieberman, J., 2003. Implications for the neural basis of social cognition for the study of schizophrenia. American Journal of Psychiatry 160, 815-824.
33. Pollack, I., Norman, D.A., 1964. A non-parametric analysis of recognition experiments. Psychonomic Science 1, 125-126.
34. Roberts, D.L., Penn, D.L., 2009. Social Cognition and Interaction Training (SCIT) for outpatientswith schizophrenia: a preliminary study. Psychiatry Research 30, 141-147.
35. Russell, T.A., Green, M.J., Simpson, I., Coltheart, M., 2008. Remediation of facial emotion perception in schizophrenia: concomitant changes in visual attention. Schizophrenia Research 103, 248-256.
36. Sergi, M., Green, M.F., Widmark, C., Reist, C., Erhart, S., Braff, D.L., Kee, K.S., Marder, S.R., Mintz, J., 2007a. Social cognition and neurocognition: effects of risperidone, olanzapine, and haloperidol. American Journal of Psychiatry 164, 1585-1592.
37. Sergi, M.J., Rassovsky, Y., Widmark, C., Reist, C., Erhart, S., Braff, D.L., Marder, S.R., Green, M.F., 2007b. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophrenia Research 90, 316-324.
38. Silver, H., Shlomo, N., Turner, T., Gur, R.C., 2002. Perception of happy and sad facial expressions in chronic schizophrenia: evidence for two evaluative systems. Schizophrenia Research 55, 171-177.
39. Silver, H., Goodman, C., Knoll, G., Isakov, V., 2004. Brief emotion training improves recognition of facial emotions in chronic schizophrenia: a pilot study. Psychiatry Research 128, 147-154.
40. Van der Gaag, M., Kern, R.S., van den Bosch, R.J., Liberman, R.P., 2002. A controlled trial of cognitive remediation in schizophrenia. Schizophrenia Bulletin 28, 167-176.
41. Woods, S.W., 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663-667.